Sunday, July 12, 2020

FDA Approves Abbott’s FreeStyle Libre 2, A Continuous Glucose Monitoring System

Abbott Laboratories announced Monday that it got FDA clearance for its integrated continuous glucose monitoring system called FreeStyle Libre 2 for diabetic patients so they can monitor their glucose levels regularly. FreeStyle Libre 2 can monitor your blood sugar almost every minute.

Statins Linked To Improved Intestinal Bacterial Flora in Obese People, Study

A new study, published in the journal Nature, has found that cholesterol-lowering statin drugs could improve the intestinal microbial flora and control inflammation in obese people. The study found that statins control inflammation caused by an unhealthy microbe called Bact2 enterotype.

Multicancer Blood Test Detects Undiagnosed Cancers, Study

A new study has shown that a multicancer blood test detected 26 undiagnosed cancer. The study was conducted on more than 9,900 women, which helped diagnosed undetected cancers, enabling potentially curative treatment. The test along with PET-CT was 99 percent specific to cancers.

Sam Lloyd Dies from Cancer at 56

Sam Lloyd, an American actor, who was best known for playing Ted Buckland on Scrubs in 95 episodes, has died after battling cancer at the age of 56. He also appeared on Cougar Town, Seinfeld, and The West Wing. He was diagnosed with a brain tumor last year.

FDA Approves Additional Doses of Cancer Drug Keytruda in Adults

The Food and Drug Administration (FDA) announced accelerated approval of the additional recommended dosage of a cancer drug called Keytruda (pembrolizumab) in adults, given the severity of the ongoing coronavirus pandemic. The FDA approved the dosage of 400 mg every 6 weeks.

Beta Cell Replacement Therapy Could Cure Type 1 Diabetes, Study

A new study has found that in vitro generated beta cells can be used as potential replacement therapy for patients with type 1 diabetes. Researchers developed a specialized stem-cell-derived beta cell that can be transplanted in diabetics so they can keep their blood sugar under control.

FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer

The Food and Drug Administration has granted accelerated approval of a drug called Trodelvy (sacituzumab govitecan-hziy) for the treatment of metastatic triple-negative breast cancer (TNBC) in adult patients. The accelerated approval would allow doctors to treat the most aggressive form of the disease.